Radiopharm Theranostics (RADX) Liabilities and Shareholders Equity (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $86.5 million as the latest value for Q2 2025.
Radiopharm Theranostics (RADX) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $86.5 million as the latest value for Q2 2025.